Chandra Bhagat Pharma Ltd
Thu 3/09/2026,16:1:0 | BSE : CBPL
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 47.88
Previous Close
₹ 50.40
Volume
5000
Mkt Cap ( ₹ Cr)
₹ 36.13
High
₹ 47.88
Low
₹ 47.88
52 Week High
₹ 52.71
52 Week Low
₹ 29.70
Book Value Per Share
₹ 43.90
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Chandra Bhagat Pharma Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Chandra Bhagat Pharma Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Chandra Bhagat Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Chandra Bhagat Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Chandra Bhagat Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Chandra Bhagat Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Chandra Bhagat Pharm - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Chandra Bhagat Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Chandra Bhagat Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Chandra Bhagat Pharm - Corrigendum Of AGM Notice
-
Chandra Bhagat Pharm - Notice Of Shareholders Meeting Scheduled On 1St September, 2026
-
Chandra Bhagat Pharm - Reg. 34 (1) Annual Report.
-
Chandra Bhagat Pharm - Board Meeting Outcome for For Approval Of Preferential Issue And Other Agenda
-
Chandra Bhagat Pharm - Board Meeting Intimation for Fund Raising Through Preferential Issue.
-
Chandra Bhagat Pharm - Non-Applicability Of CG Report
Key fundamentals
Evaluate the intrinsic value of Chandra Bhagat Pharma Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 49.6338 | 50.8291 | 45.4358 | 46.4234 | 46.4812 |
| Liabilities | 49.6338 | 50.8291 | 45.4358 | 46.4234 | 46.4812 |
| Equity | 7.5451 | 7.5451 | 7.5451 | 7.5451 | 7.5451 |
| Gross Profit | 3.8531 | 0.6651 | -7.0418 | 3.321 | 2.6759 |
| Net Profit | 3.0461 | 0.8578 | 1.5303 | 0.9054 | 0.7967 |
| Cash From Operating Activities | 9.2357 | -5.5818 | 6.1756 | 5.2642 | 12.4623 |
| NPM(%) | 2.61 | 0.96 | 0.69 | 0.75 | 0.84 |
| Revenue | 116.2717 | 88.8054 | 221.3719 | 119.6722 | 94.0756 |
| Expenses | 112.4186 | 88.1403 | 228.4137 | 116.3512 | 91.3997 |
| ROE(%) | 9.19 | 2.58 | 4.61 | 2.73 | 2.4 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Chandra Bhagat Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| No Records Found | ||||||
Company Info
The Company was incorporated as "Chandra Bhagat Pharma Private Limited" at Mumbai on March 10, 2003, under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Maharashtra, Mumbai. Consequent upon the conversion of our Company from Private Limited Company to Public Limited Company, the name of our Company was changed to "Chandra Bhagat Pharma Limited" and fresh Certificate of Incorporation consequent upon the conversion from Private Limited Company to Public Limited Company dated March 20, 2019 was issued by the Registrar of Companies, RoC - Mumbai. The CIN of the Company is U24230MH2003PLC139534.MAJOR EVENTS2003Incorporation of our company in the name of Chandra Bhagat Pharma Private Limited2015Company has entered into supply and distribution agreement on November 9, 2015 with Sinopharm India Private Limited ("Sinopharma"), a subsidiary company of China National Pharmaceutical Group for importing the vaccines known as "HEPATITIS A (HepA).2017Registration for supply of API like Urokinase (Cardiac), L-Asparaginase (Oncology), Heparin Sodium (Nephrology), and Enoxaparin Sodium (Cardiac).2019The Company got converted into Public Limited Company
The Company was incorporated as "Chandra Bhagat Pharma Private Limited" at Mumbai on March 10, 2003, under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Maharashtra, Mumbai. Consequent upon the conversion of our Company from Private Limited Company to Public Limited Company, the name of our Company was changed to "Chandra Bhagat Pharma Limited" and fresh Certificate of Incorporation consequent upon the conversion from Private Limited Company to Public Limited Company dated March 20, 2019 was issued by the Registrar of Companies, RoC - Mumbai. The CIN of the Company is U24230MH2003PLC139534.MAJOR EVENTS2003Incorporation of our company in the name of Chandra Bhagat Pharma Private Limited2015Company has entered into supply and distribution agreement on November 9, 2015 with Sinopharm India Private Limited ("Sinopharma"), a subsidiary company of China National Pharmaceutical Group for importing the vaccines known as "HEPATITIS A (HepA).2017Registration for supply of API like Urokinase (Cardiac), L-Asparaginase (Oncology), Heparin Sodium (Nephrology), and Enoxaparin Sodium (Cardiac).2019The Company got converted into Public Limited Company
Read More
Parent Organisation
Chandra Bhagat Pharma Ltd.
Founded
10/03/2003
Managing Director
Mr.Hemant Chandravadan Bhagat
NSE Symbol
FAQ
The current price of Chandra Bhagat Pharma Ltd is
The 52-week high for Chandra Bhagat Pharma Ltd is
The market capitalization of Chandra Bhagat Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Chandra Bhagat Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Chandra Bhagat Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Chandra Bhagat Pharma Ltd shares.
The CEO of Chandra Bhagat Pharma Ltd is Mr.Hemant Chandravadan Bhagat, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
